Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents.
Peña-Corona SI, Hernández-Parra H, Bernal-Chávez SA, Mendoza-Muñoz N, Romero-Montero A, Del Prado-Audelo ML, Cortés H, Ateşşahin DA, Habtemariam S, Almarhoon ZM, Abdull Razis AF, Modu B, Sharifi-Rad J, Leyva-Gómez G. Peña-Corona SI, et al. Among authors: habtemariam s. Front Pharmacol. 2023 Jun 6;14:1206334. doi: 10.3389/fphar.2023.1206334. eCollection 2023. Front Pharmacol. 2023. PMID: 37346293 Free PMC article. Review.
New insights into the anticancer therapeutic potential of maytansine and its derivatives.
Zafar S, Armaghan M, Khan K, Hassan N, Sharifi-Rad J, Habtemariam S, Kieliszek M, Butnariu M, Bagiu IC, Bagiu RV, Cho WC. Zafar S, et al. Among authors: habtemariam s. Biomed Pharmacother. 2023 Sep;165:115039. doi: 10.1016/j.biopha.2023.115039. Epub 2023 Jun 24. Biomed Pharmacother. 2023. PMID: 37364476 Free article. Review.
Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure-activity relationship, and prospects for clinical advancement.
Elsaman T, Muddathir AM, Mohieldin EAM, Batubara I, Rahminiwati M, Yamauchi K, Mohamed MA, Asoka SF, Büsselberg D, Habtemariam S, Sharifi-Rad J. Elsaman T, et al. Among authors: habtemariam s. Pharmacol Rep. 2024 Apr;76(2):287-306. doi: 10.1007/s43440-024-00586-5. Epub 2024 Mar 25. Pharmacol Rep. 2024. PMID: 38526651 Review.
New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives.
Reyes-Hernández OD, Figueroa-González G, Quintas-Granados LI, Hernández-Parra H, Peña-Corona SI, Cortés H, Kipchakbayeva A, Mukazhanova Z, Habtemariam S, Leyva-Gómez G, Büsselberg D, Sharifi-Rad J. Reyes-Hernández OD, et al. Among authors: habtemariam s. Drug Dev Res. 2024 Apr;85(2):e22175. doi: 10.1002/ddr.22175. Drug Dev Res. 2024. PMID: 38567708 Review.
Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy - A comprehensive review.
Ali MA, Khan N, Ali A, Akram H, Zafar N, Imran K, Khan T, Khan K, Armaghan M, Palma-Morales M, Rodríguez-Pérez C, Caunii A, Butnariu M, Habtemariam S, Sharifi-Rad J. Ali MA, et al. Among authors: habtemariam s. Food Sci Nutr. 2024 Feb 1;12(5):3046-3067. doi: 10.1002/fsn3.3986. eCollection 2024 May. Food Sci Nutr. 2024. PMID: 38726411 Free PMC article. Review.
187 results